Company News • Endpoint Arena

News Updates

Wed, May 13, 2026

1 updates

8:00 AM

Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress

Presentation / Abstractkyowakirin.com

Thu, May 7, 2026

2 updates

8:00 AM

Kyowa Kirin Plans the Creation of State-of-the-Art Research Hub to Further Strengthen Drug Discovery Capabilities

kyowakirin.com

8:00 AM

Announcement of Consolidated Financial Results Fiscal 2026 First Quarter

kyowakirin.com

Fri, Apr 24, 2026

1 updates

8:00 AM

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

kyowakirin.com

Tue, Mar 3, 2026

1 updates

7:00 AM

Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials

kyowakirin.com